Hypermarcas (OTCMKTS:HYPMY) Share Price Passes Below 50-Day Moving Average – Here’s What Happened

Shares of Hypermarcas (OTCMKTS:HYPMYGet Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $4.37 and traded as low as $4.00. Hypermarcas shares last traded at $4.1125, with a volume of 736 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy”.

View Our Latest Research Report on HYPMY

Hypermarcas Stock Performance

The firm has a market cap of $2.90 billion, a PE ratio of 8.57 and a beta of 0.70. The stock has a 50-day moving average price of $4.37 and a 200 day moving average price of $4.40. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.27 and a quick ratio of 0.84.

Hypermarcas (OTCMKTS:HYPMYGet Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The firm had revenue of $383.13 million for the quarter. Research analysts forecast that Hypermarcas will post 0.53 earnings per share for the current year.

Hypermarcas Company Profile

(Get Free Report)

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.

Featured Stories

Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.